CollPlant Biotechnologies Regains Nasdaq Compliance

9/22/2026
Impact: 50
Healthcare

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) has received formal notification from Nasdaq confirming that it has regained compliance with Listing Rule 5550(a)(2), which mandates a minimum bid price of $1.00 per share for its common stock.

AI summary, not financial advice

Share: